Development of a Patient Decision Aid on the Choice of Diabetes Medication for Filipino Patients with Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.15605/jafes.034.01.08Keywords:
decision aid, decision support technique, decision support model, patient decision making, interactive health communication, risk communicationAbstract
Objective. To develop a locally adapted patient decision aid (PtDA) on treatment intensification among Filipino patients with Type 2 Diabetes Mellitus and to test the feasibility of using PtDAs in a low middle-income country.
Methodology. A qualitative approach and an iterative process of development of a PtDA were employed for this study. We describe the process of developing a Filipino version of the Diabetes Medication Decision Aid. This PtDA was designed to help the patient choose the appropriate treatment intensification based on his own values and preferences, in consultation with his physician. The process involved decisional needs assessment through focus group discussions and key informant interviews, systematic literature review, iterative process of the development of a PtDA with clinical encounters (pilot testing), and preliminary field testing.
Results. Decisional needs assessment revealed that Filipino patients are open to participate in shared decision-making if given the opportunity, including those with low socioeconomic status who likely have low health literacy. Physicians prefer to have visual aid tools to help them support their patient’s decision-making. A PtDA prototype of a set of flash cards in Filipino was created and revised in an iterative method. We developed a more visually appealing tool after inputs from the expert panel and patient advisory group. Its use during clinical encounters provided additional insights from patients and clinicians on how to improve the PtDA. Preliminary field testing showed that its use is feasible in the target patient population.
Conclusion. Filipino patients, clinicians, and diabetes nurse educators have contributed to the creation of the first Filipino PtDA for diabetes treatment intensification.
Downloads
References
Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-9. PMID: 25538310. https://doi.org/10.2337/dc14-2441.
Mearns ES, Sobieraj DM, White CM, et al. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: A network meta-analysis. PLoS One. 2015;10(4):e0125879. PMID: 25919293. PMCID: PMC4412636. https://doi.org/10.1371/journal.pone.0125879.
Bennett WL, Maruthur NM, Singh S, et al. Comparative effectiveness and safety of medications for type 2 diabetes : An update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602-13. PMID: 21403054. PMCID: PMC3733115. https://doi.org/10.7326/0003-4819-154-9-201105030-00336.
Bolen S, Feldman L, Vassy J, et al. Systematic review: Comparative effectiveness and saftey of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):389-99. PMID: 17638715.
Bailey RA, Pfeifer M, Shillington AC, et al. Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict. BMC Health Serv Res. 2015;16:10. PMID:26762150. PMCID:PMC4712511. https://doi.org/10.1186/s12913-016-1262-4.
Barry MJ, Edgman-Levitan S. Shared decision making - pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-1. PMID: 22375967. https://doi.org/10.1056/NEJMp1109283.
Rodriguez-Gutierrez R, Gionfriddo MR, Ospina NS, et al. Shared decision making in endocrinology: Present and future directions. Lancet Diabetes Endocrinol. 2016;4(8):706-16. PMID: 26915314. https://doi.org/10.1016/S2213-8587(15)00468-4.
Hazlehurst JM, Armstrong MJ, Sherlock M, et al. A comparative quality assessment of evidence-based clinical guidelines in endocrinology. Clin Endocrinol (Oxf). 2013;78(2):183-90. PMID: 22625723. https://doi.org/10.1111/j.1365-2265.2012.04441.x.
Brito JP, Domecq JP, Murad MH, Guyatt GH, Montori VM. The Endocrine Society guidelines: When the confidence cart goes before the evidence horse. J Clin Endocrinol Metab. 2013;98(8):3246-52. PMID: 23783104. https://doi.org/10.1210/jc.2013-1814.
Légaré F, Ratté S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: Update of a systematic review of health professionals’ perceptions. Patient Educ Couns. 2008;73(3):526-35. PMID: 18752915 https://doi.org/10.1016/j.pec.2008.07.018.
Belcher VN, Fried TR, Agostini JV, Tinetti ME. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med. 2006;21(4):298-303. PMID: 16686804. PMCID: PMC1484726. https://doi.org/10.1111/j.1525-1497.2006.00329.x.
Stacey D, Légaré F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews 2017. Issue 4, Article No.: CD001431. https://doi.org//10.1002/14651858.CD001431.pub5.
Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid. Arch Intern Med. 2009;169(17):1560-8. PMID: 19786674. https://doi.org/10.1001/archinternmed.2009.293.
Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4):219-26. PMID: 18418028. https://doi.org/10.1159/000126073.
Montori VM, Gafni A, Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: The case of diabetes. Health Expect. 2006;9(1):25-36. PMID: 16436159. PMCID: PMC5060323. https://doi.org/10.1111/j.1369-7625.2006.00359.x.
Glasgow RE, Hiss RG, Anderson RM, et al. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care. 2001;24(1):124-30. PMID: 11194217.
Heisler M. Actively Engaging patients in treatment decision making and monitoring as a strategy to improve hypertension outcomes in diabetes mellitus. Circulation. 2008;117(11):1355-7. PMID: 18347219. https://doi.org/10.1161/CIRCULATIONAHA.108.764514.
Shillington AC, Col N, Bailey RA, Jewell MA. Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone. Patient Prefer Adherence. 2015;9:609. PMID: 25995622. PMCID: PMC4425316. https://doi.org/10.2147/PPA.S82555.
Shah ND, Mullan RJ, Breslin M, Yawn BP, Ting HH, Montori VM. Translating comparative effectiveness into practice: The case of diabetes medications. Med Care. 2010;48(6 Suppl):S153-8. PMID: 20473211. https://doi.org/10.1097/MLR.0b013e3181d5956c.
den Ouden H, Vos RC, Reidsma C, Rutten GE. Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: Design of a cluster randomised (OPTIMAL) trial. BMC Fam Pract. 2015;16:27. PMID: 25887759. PMCID: PMC4369865. https://doi.org/10.1186/s12875-015-0230-0.
Mathers N, Ng CJ, Campbell MJ, Colwell B, Brown I, Bradley A. Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: A cluster randomised controlled trial (PANDAs) in general practice. BMJ Open. 2012;2(6):e001469. https://doi.org/10.1136/bmjopen-2012-001469.
Corser W, Holmes-Rovner M, Lein C, Gossain V. A shared decision-making primary care intervention for type 2 diabetes. Diabetes Educ. 2007;33(4):700-8.
PMID: 17684171. https://doi.org10.1177/0145721707304086.
Denig P, Dun M, Schuling J, Haaijer-Ruskamp FM, Voorham J. The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): Study protocol for a randomised controlled trial. Trials. 2012;13(1):219. PMID: 23171524. PMCID: PMC3561233. https://doi.org/10.1186/1745-6215-13-219.
Branda ME, LeBlanc A, Shah ND, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Serv Res. 2013;13(1):301. https://doi.org/10.1186/1472-6963-13-301.
Stiggelbout AM, Van der Weijden T, De Wit MPT, et al. Shared decision making: Really putting patients at the centre of healthcare. BMJ. 2012;344:e256. PMID: 22286508. https://doi.org/10.1136/bmj.e256.
Hibbard JH, Greene J, Tusler M. Improving the outcomes of disease management by tailoring care to the patient’s level of activation. Am J Manag Care. 2009;15(6):353-60. PMID: 19514801.
Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S2. PMID: 24625093. PMCID: PMC4044159. https://doi.org/10.1186/1472-6947-13-S2-S2.
O’Connor A, Stacey D, Boland L. Ottawa decision support tutorial, 2015. https://decisionaid.ohri.ca/odst/pdfs/odst.pdf.
Breslin M, Mullan RJ, Montori VM. The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Educ Couns. 2008;73(3):465-72. PMID: 18771876. https://doi.org/10.1016/j.pec.2008.07.024.
Mendoza MJ, Sacdalan DB, Palileo-Villanueva LA. Shared decision making at the general internal medicine outpatient clinic of the Philippine General Hospital: Patient’s perspective. J Particip Med. 2016;8(e14).
Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010;80(1):94-9. PMID: 19879711. https://doi.org/10.1016/j.pec.2009.09.034.
Elwyn G, Edwards A, Wensing M, Hood K, Atwell C, Grol R. Shared decision making: Developing the OPTION scale for measuring patient involvement. Qual Saf Health Care. 2003;12(2):93-9. PMID: 12679504. PMCID: PMC1743691.
Elwyn G, Hutchings H, Edwards A, et al. The OPTION scale: Measuring the extent that clinicians involve patients in decision-making tasks. Heal Expect. 2005;8(1):34-42. PMID: 15713169. PMCID: PMC5060272. https://doi.org/10.1111/j.1369-7625.2004.00311.x.
Palmer SC, Mavridis D, Nicolucci A, et al. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: A meta-analysis. JAMA. 2016;316(3):313-24. PMID: 27434443. https://doi.org/10.1001/jama.2016.9400.
Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med. 2016;164(11):740-51. PMID: 27088241. https://doi.org/10.7326/M15-2650.
Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials. JAMA. 2007;298(10):1180-8. PMID: 17848652. https://doi.org/10.1001/jama.298.10.1180.
Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: A meta-analysis. CMAJ. 2009;180(1):32-9. PMID: 19073651. PMCID: PMC2612065. https://doi.org/10.1503/cmaj.080486.
Berlie HD, Kalus JS, Jaber LA. Thiazolidinediones and the risk of edema: A meta-analysis. Diabetes Res Clin Pract. 2007;76(2):279-89. PMID: 17055103. https://doi.org/10.1016/j.diabres.2006.09.010.
Gooßen K, Gräber S. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: Systematic review and meta-analysis. Diabetes, Obes Metab. 2012;14(12):1061-72. PMID: 22519906. https://doi.org/10.1111/j.1463-1326.2012.01610.x.
Shyangdan DS, Uthman OA, Waugh N. SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: A systematic review and network meta-analysis. BMJ Open. 2016;6(2):e009417. PMID: 26911584. PMCID: PMC4769433. https://doi.org/10.1136/bmjopen-2015-009417.
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial. JAMA. 2015;314(7):687-99. PMID: 26284720. https://doi.org/10.1001/jama.2015.9676.
Rosenstock J, Fonseca V, McGill JB, et al. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: A long-term, randomised, open-label study. Diabetologia. 2009;52(9):1778-88. PMID: 19526210. PMCID: PMC2723680. https://doi.org/10.1007/s00125-009-1415-7.
Zhu H, Zhu Y, Leung SW. Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: A meta-analysis of randomised controlled trials. BMJ Open. 2016;6(9):e010524. PMID: 27591016. PMCID: PMC5020874. https://doi.org/10.1136/bmjopen-2015-010524.
Kennedy L. Self-monitoring of blood glucose in type 2 diabetes. Diabetes Care. 2009;24(6):977-8. https://doi.org/10.2337/diacare.24.6.977.
Schnell O, Felton AM. Self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches. Diabetes Spectr. 2013;26(2):107-11. https://doi.org/10.2337/diaspect.26.2.107.
Elwyn G, Edwards A, Hood K, et al. Achieving involvement: Process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract. 2004;21(4):337-46. PMID: 15249520. https://doi.org/10.1093/fampra/cmh401.
McCaffery KJ, Holmes-Rovner M, Smith SK, et al. Addressing health literacy in patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S10. PMID: 24624970. PMCID: PMC4042520. https://doi.org/10.1186/1472-6947-13-S2-S10.
McCaffery KJ, Smith SK, Wolf M. The challenge of shared decision making among patients with lower literacy: A framework for research and development. Med Decis Mak. 2010;30(1):35-44. PMID: 19692709. https://doi.org/10.1177/0272989X09342279.
Karagiannis T, Liakos A, Branda ME, et al. Use of the diabetes medication choice decision aid in patients with type 2 diabetes in Greece: A cluster randomised trial. BMJ Open. 2016;6(11):e012185. https://doi/org/10.1136/bmjopen-2016-012185.
Montori VM, Rothman RL. Weakness in numbers. The challenge of numeracy in health care. J Gen Intern Med. 2005;20(11):1071-2. PMID: 16307637. PMCID: PMC1490258. https://doi.org/10.1111/j.1525-1497.2005.051498.x51.
van Weert JC, van Munster BC, Sanders R, Spijker R, Hooft L, Jansen J. Decision aids to help older people make health decisions: A systematic review and meta-analysis. BMC Med Inform Decis Mak. 2016;16:45. PMID: 27098100. PMCID: PMC4839148. https://doi.org/10.1186/s12911-016-0281-8.
Mata R, Schooler LJ, Rieskamp J. The aging decision maker: Cognitive aging and the adaptive selection of decision strategies. Psychol Aging. 2007;22(4):796-810. PMID: 18179298. https://doi.org/10.1037/0882-7974.22.4.796.
*Link to Demo: https://drive.google.com/file/d/1uW-qRM4GrLYLLwIIafFlKwZRG8Matxw6/view?usp=sharing
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
